When examining the differences in the expression levels between control subjects and the entire T2DM patient group, we found significant differences in the expression levels of GLUT1, GLUT3, URAT1, and MCT1 (Table 2; Fig. 1). This evidence concerns the gene SLC16A1 and type 2 diabetes mellitus.